Experts Forecast 2024, Part 4: Cutting-edge Tech for Oncology Drug Discovery
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
Progress Against Cancer
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
January is Cervical Cancer Awareness Month. Here's the latest on prevention, screening, and treatment.
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional...
Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and...
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after...
Study supports the use of immune checkpoint inhibitors in an understudied population.
An implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
Some women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.